Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    Intensive care medicine 22 (1996), S. 1406-1409 
    ISSN: 1432-1238
    Schlagwort(e): Keywords Respiratory failure ; Mitochondrial myopathy ; Acid maltase deficiency ; Intermittent positive pressure ventilation ; Carnitine palmitoyl transferase deficiency
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract   Objective: To describe how patients cope with the propos-al of treatment with intermittent artificial ventilation after acute respiratory failure due to progressive respiratory muscle weakness. Design: Case series, follow-up study. Setting: Neurological intensive care unit (ICU). Patients: 7 consecutive patients with metabolic myopathy treated for acute respiratory failure between 1983 and 1992. interventions: Intermittent positive pressure ventilation (IPPV) via tracheostomy. Measurements and results: Symptoms of chronic hypoventilation preceded acute respiratory failure for months. With one exception, patients were mainly disabled from respiratory muscle weakness and sleep-related breathing disorders. IPPV was recommended to prevent recurrent respiratory failure. Two of 28.8nthree patients who accepted home IPPV returned to full-time jobs. One patient, who decided against IPPV, died from CO2 narcosis several months after discharge. All patients adhered to the respiratory regimen once instituted. Conclusions: Acute respiratory failure in chronic myopathy is heralded by daytime drowsiness. IPPV, or at least regular monitoring of waking and sleeping partial pressure of carbon dioxide, is highly recommended even if weaning is successful. IPPV improved quality of life. The treatment strategy at discharge from the ICU should be optimal, as patients are reluctant to modify regimens.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Digitale Medien
    Digitale Medien
    Springer
    Intensive care medicine 22 (1996), S. 1406-1409 
    ISSN: 1432-1238
    Schlagwort(e): Respiratory failure ; Mitochondrial myopathy ; Acid maltase deficiency ; Intermittent positive pressure ventilation ; Carnitine palmitoyl transferase deficiency
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Objective To describe how patients cope with the proposal of treatment with intermittent artificial ventilation after acute respiratory failure due to progressive respiratory muscle weakness. Design Case series, follow-up study. Setting Neurological intensive care unit (ICU). Patients 7 consecutive patients with metabolic myopathy treated for acute respiratory failure between 1983 and 1992. Interventions Intermittent positive pressure ventilation (IPPV) via tracheostomy. Measurements and results Symptoms of chronic hypoventilation preceded acute respiratory failure for months. With one exception, patients were mainly disabled from respiratory muscle weakness and sleep-related breathing disorders. IPPV was recommended to prevent recurrent respiratory failure. Two of three patients who accepted home IPPV returned to full-time jobs. One patient, who decided against IPPV, died from CO2 narcosis several months after discharge. All patients adhered to the respiratory regimen once instituted. Conclusions Acute respiratory failure in chronic myopathy is heralded by daytime drowsiness. IPPV, or at least regular monitoring of waking and sleeping partial pressure of carbon dioxide, is highly recommended even if weaning is successful. IPPV improved quality of life. The treatment strategy at discharge from the ICU should be optimal, as patients are reluctant to modify regimens.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...